Cybrexa Revenue and Competitors
Estimated Revenue & Valuation
- Cybrexa's estimated annual revenue is currently $5.3M per year.
- Cybrexa's estimated revenue per employee is $155,000
Employee Data
- Cybrexa has 34 Employees.
- Cybrexa grew their employee count by 31% last year.
Cybrexa's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President & CEO | Reveal Email/Phone |
2 | Chief Scientific Advisor & Scientific co-founder | Reveal Email/Phone |
3 | Chief Medical Advisor & Scientific co-founder | Reveal Email/Phone |
4 | CFO / COO | Reveal Email/Phone |
5 | VP Clinical Operations | Reveal Email/Phone |
6 | Director, FP&A | Reveal Email/Phone |
7 | Director Biology | Reveal Email/Phone |
8 | Director Chemistry | Reveal Email/Phone |
9 | Laboratory Manager | Reveal Email/Phone |
10 | Research Scientist | Reveal Email/Phone |
Cybrexa Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.2M | 1 | 0% | N/A | N/A |
#2 | $3.3M | 21 | -25% | N/A | N/A |
#3 | $9.8M | 81 | -10% | N/A | N/A |
#4 | $1.7M | 11 | 450% | N/A | N/A |
#5 | $20.3M | 131 | -23% | N/A | N/A |
#6 | $5.4M | 35 | -22% | N/A | N/A |
#7 | $2M | 13 | 44% | N/A | N/A |
#8 | $2.8M | 18 | 20% | N/A | N/A |
#9 | $0.3M | 4 | 0% | N/A | N/A |
#10 | $3.6M | 23 | -12% | N/A | N/A |
What Is Cybrexa?
Cybrexa is a privately-held biotechnology company dedicated to developing next-generation tumor-targeted cancer therapies using its alphalexâ„¢ platform. The Company's lead candidate, CBX-12, an alphalexâ„¢-exatecan conjugate, is expected to enter Phase I in 2021 in advanced solid tumors. Cybrexa also has other preclinical toxin conjugate programs as well as synthetic lethality programs. Cybrexa was founded by physician-scientists and has an experienced management team that has built numerous successful life sciences companies. For more information about Cybrexa, please visit www.cybrexa.com.
keywords:N/A
N/A
Total Funding
34
Number of Employees
$5.3M
Revenue (est)
31%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cybrexa News
In addition to Cybrexa, Bindra founded Alphina Therapeutics, B3 Therapeutics and Helix Therapeutics, which are all biotechnology companies that...
Other Companies in New Haven
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.9M | 34 | 17% | N/A |
#2 | $7.5M | 34 | 0% | N/A |
#3 | $4.9M | 34 | 3% | N/A |
#4 | $4.7M | 34 | 10% | N/A |
#5 | $7.3M | 34 | 0% | N/A |